一个随机的,受控的临床研究低分子量肝素改善怀孕结果在PCOS妇女接受试管婴儿:研究协议
Ou Huang1, Haixia Ding2,3, Dandan Wu4,5
1Department of General Surgery, Comprehensive Breast Health Center, Ruijing Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Trials
|January 3, 2024
概括
这项研究调查了低分子量肝素 (LMWH) 是否改善了经过IVF-FET的多囊性卵巢综合征 (PCOS) 妇女的怀孕结果. 这项研究旨在确定LMWH是否减少了早期怀孕损失,并增加了这一群体的活产率.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 血栓形成和血液静止.
- 不孕症治疗 不孕症治疗
背景情况:
- 多囊卵巢综合征 (PCOS) 影响10-15%的生殖年龄妇女,增加了3-8倍的早期怀孕损失风险.
- 结核复合综合症与前血栓状况和免疫系统过度激活有关,导致不良妊娠结果.
- 用低分子量肝素 (LMWH) 进行抗凝固治疗是减轻这些风险的潜在策略,尽管在怀孕早期对PCOS的使用尚未研究.
研究的目的:
- 调查LMWH作为辅助疗法的疗效,以改善经过体外受精-冷胚胎移植 (IVF-FET) 的PCOS妇女的妊娠结果.
主要方法:
- 一项随机对照试验,涉及356名年龄在20-38岁的PCOS妇女,接受试管婴儿-FET.
- 参与者被分为接受LMWH的研究组和接受标准激素治疗的控制组.
- 主要结局是正在进行的怀孕,定义为怀孕12周后超声波上的活胎儿.
主要成果:
- 该研究方案旨在在LMWH和对照组之间比较正在进行的怀孕率,临床怀孕率,活产率和早期怀孕丧失率.
- 生物化学怀孕将在胚胎移植后14天得到确认,两周后通过超声波确认子宫内怀孕.
结论:
- 这项研究是第一个评估LMWH在接受IVF-FET的PCOS患者的疗效的方案.
- 这些发现将提供关于LMWH在改善IVF-FET成功率和减少PCOS妇女怀孕并发症中的作用的关键数据.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
In Vitro Fertilization
282
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
282


